Diabetes experts to discuss VERTIS CV trial outcome
A panel of diabetes multidisciplinary primary and secondary care experts will discuss their main learning points from the latest SGLT2 inhibitor CV outcomes trial VERTIS CV.
The live webinar, on Wednesday, July 1 at 7pm, is part of the DPC Summer Forum which is bringing together key opinion leaders who are deciphering the main outcomes from the American Diabetes Association (ADA) Scientific Conference.
The Summer Forum is a CPD accredited, free-to-access digital series online sessions made up of interactive panel discussions and debates with top diabetes experts.
The sessions are being supported by AstraZeneca, which is leading the way in online education in the absence of face-to-face education during the COVID-19 pandemic.
Wednesday’s webinar will discuss the findings of the VERTIS CV trial which looked at the safety and health benefits of people with type 2 diabetes taking ertugliflozin.
The taskforce of experts will distil their main learning points from the VERTIS-CV session as they watched as part of ADA and discuss how this learning might be implemented into day-to-day clinical practice.
Dr Kevin Fernando, who forms part of the panel of multidisciplinary experts, said: “The trial population of VERTIS-CV was almost identical to the EMPAREG trial but the outcomes were not replicated.
“This finding is really interesting and I think will form the basis of our discussion during the DPC webinar.”
The debate panel is
- Dr. David Strain Clinical Senior Lecturer, Diabetes and Vascular Research Centre
- Dr. Kevin Fernando GP Partner & Medical Education & Scottish Lead
- Dr Derek Connnolly – Consultant Interventional Cardiologist
- Dr Jim Moore GP and GPSI Cardiology President, Primary Care Cardiovascular Society
- Dr. Marc Evans Consultant Diabetologist
- Debbie Hicks Nurse Consultant – Diabetes, Medicus Health Partners, Co-Chair
- Dr Patrick Holmes, GPwSI Diabetes
- Hannah Beba, Senior Pharmacist Diabetes and Endocrinology
The next sessions are due to take place on July 8, July 15 and July 22.
To register for free, click here.
View the full programme here.